Skip to Content

WPI 3620 (Armodafinil 50 mg)

Pill with imprint WPI 3620 is White, Round and has been identified as Armodafinil 50 mg. It is supplied by Watson Laboratories, Inc. .

Armodafinil is used in the treatment of narcolepsy; shift work sleep disorder; obstructive sleep apnea/hypopnea syndrome and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3620

Armodafinil

Imprint
WPI 3620
Strength
50 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3620

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.